Antibiotics to prevent urinary infections in kidney transplant patients
Treatments studied
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether continuing or stopping a specific antibiotic (TMP-SMX) after the first 6 months can prevent urinary tract infections (UTIs) in kidney transplant recipients who are at high risk for them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a kidney transplant at UCSF in the last 6 months
- You can swallow capsules by mouth
- Your kidney function (GFR) is above a certain level (more than 30)
- You have taken TMP-SMX without stopping for the first 6 months after your transplant
- You are at high risk for UTIs, for example due to diabetes, a history of UTIs, bladder issues, or certain kidney conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving a specific antibiotic can help prevent bloodstream infections in people who recently had a kidney transplant. It is for patients who have a significant amount of bacteria in their urine within the first month after surgery.
This trial tests if using a personalized antibiotic approach before surgery can reduce infections compared to the usual one-size-fits-all antibiotics. It focuses on people having their bladder removed (cystectomy) with a specific type of urinary diversion.
This trial tests if taking a common antibiotic (TMP/SMX) after a kidney injury can help prevent infections after you leave the hospital. It might be an option if you had acute kidney injury during your hospital stay and are being discharged to recover at home or a rehabilitation facility.
This study compares two different doses of an antibiotic (TMP-SMX) to prevent a serious lung infection called Pneumocystis pneumonia that can occur after kidney transplant. The goal is to find the safest, most effective dose for transplant patients.
This trial tests how long kidney transplant patients should take a common antibiotic (sulfamethoxazole) to prevent a lung infection called PJP. You may join if you are between 18 and 70 and have had a kidney transplant.
This trial tests a phage (virus that kills bacteria) treatment for women who have had a kidney transplant and keep getting urinary tract infections (UTIs) caused by E. coli bacteria. It aims to see if this therapy can help prevent future infections.
Hear when a new Kidney Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.